Extended-Release Risperidone Injectable Staves Off Schizophrenia Relapse
(MedPage Today) -- An investigational long-acting antipsychotic containing risperidone, known as TV-46000, was able to significantly delay time to relapse in patients with schizophrenia, according to the phase III RISE study.
Patients treated...
Read more »